Three-plane CCI comparable with single-plane outcomes

Article

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

Dr Marco Lombardo et al., Fondazione G.B. Bietti IRCCS, Rome, Italy, performed inflation testing in 14 human eye globes to assess the topographic response to the cornea to CCIs.

The eyes were divided into two group, with first group undergoing a 2.75 mm three-plane CCI created with an FS laser and the control group receiving a 2.75 mm manual CCI using disposable angled knives.

A Scheimpflug topographer was used to obtain topographic maps of the anterior and posterior cornea, keratometric data was used to evaluate the curvature changes of the cornea and vector analysis was used to identify the changes of corneal astigmatism.

The mean postoperative change of the anterior keratometric power was 0.04 ± 0.39 and 0.05 ± 0.51 in the FS laser and control groups, respectively and the mean change of the posterior corneal keratometric power was 0.16 ± 0.19 and 0.15 ± 0.18 D, respectively.

It was found that the average change of the anterior and posterior corneal astigmatism vector magnitude was 0.17 D or less in both groups. The team also recorded an insignificant against-the-rule astigmatic change in the anterior and posterior corneal interfaces after both CCI techniques.

To read the abstract please visit the Journal of Refractive Surgery.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.